Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
gene therapy
4
×
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
clinical trials
medical devices
novartis
abbvie
akcea therapeutics
anemia
biogen
crispr
duchenne muscular dystrophy
What
bio
4
×
roundup
cancer
crispr
days
new
pharma
abbvie’s
ahead
allogene
august
biofourmis
biopharma
biotech
bucks
busy
celebrate
chance
congress
congressional
corner
day
decisions
devices
diversity
drugs
executives
fda
feud
forward
group
holiday
hot
immunotherapy
investors
ipo
isn’t
juno
known
labor
Language
unset
Current search:
glaxosmithkline
×
bio
×
" gene therapy "
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More